Brincidofovir (CMX001) is an experimental antiviral drug being developed by Chimerix for the treatment of cytomegalovirus. It also has activity against adenoviruses BK virus and herpes simplex viruses.Brincidofovir is a prodrug of cidofovir.
This page contains content from the copyrighted Wikipedia article "Brincidofovir"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.